The introduction of nicotinamide as a nicotine substitution in e-cigarette and smokeless solutions represents a major regulatory challenge for that FDA. Nicotinamide does not have nicotinic receptor agonist action and is thought to act as a sedative at high dosages6. The claims created by Nicotine River, ECBlend, and various sellers that their prod